Last edited by Zulugrel
Monday, August 3, 2020 | History

4 edition of glycation hypothesis of atherosclerosis found in the catalog.

glycation hypothesis of atherosclerosis

by Camilo A. L. S. Colaco

  • 348 Want to read
  • 21 Currently reading

Published by Chapman & Hall, Landes Bioscience in New York, Austin, Tex., U.S.A .
Written in English

    Subjects:
  • Atherosclerosis -- Pathophysiology.,
  • Atherosclerosis -- Etiology.,
  • Glycosylation.,
  • Diabetes -- Complications.,
  • Atherosclerosis -- physiopathology.,
  • Atherosclerosis -- etiology.,
  • Glycosylation.

  • Edition Notes

    Includes bibliographical references and index.

    StatementCamilo A.L.S. Colaco.
    SeriesMedical intelligence unit, Medical intelligence unit (Unnumbered)
    Classifications
    LC ClassificationsRC692 .C63 1997
    The Physical Object
    Pagination219 p. :
    Number of Pages219
    ID Numbers
    Open LibraryOL662612M
    ISBN 100412114917, 1570594449
    LC Control Number97008105

    Accelerated atherosclerosis and microvascular complications are perhaps the leading cause of coronary heart disease, blindness and renal failure, which could account for disabilities and high mortality rates in patients with diabetes. the process of formation and accumulation of advanced glycation end products (AGEs) and their mode of. 10 hours ago  One possibility is that the intermediates are modified proteins known as advanced glycation end products (AGEs), which could form when hydrocodone or oxycodone metabolites react with a carbohydrate.

    WASHINGTON, Aug. 17, -- In addition to possibly developing opioid use disorder, those who take opioids long term, including patients who have been prescribed the drugs for pain relief, can. Our study aimed to identify the relationship between advanced glycation end products (AGEs), soluble receptor for advanced glycation end products (sRAGE), the AGEs/sRAGE, and uric acid (UA) levels in selected atherosclerosis diseases, i.e., abdominal aortic aneurysms (AAA), aortoiliac occlusive disease (AIOD), and chronic kidney disease (CKD), resulting from apparent differences in oxidative.

    Title: Receptor for Advanced Glycation End Products (RAGE): A Novel Therapeutic Target for Diabetic Vascular Complication VOLUME: 14 ISSUE: 5 Author(s):Sho-ichi Yamagishi, Kazuo Nakamura, Takanori Matsui, Yoshihiro Noda and Tsutomu Imaizumi Affiliation:Division of Cardiovascular Medicine, Department of Medicine, Kurume , Japan.   Park, L. et al. Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts. Nature Med. 4, – (). CAS.


Share this book
You might also like
Playground management for local councils

Playground management for local councils

The place of religion in Erik H. Eriksons theory of human development

The place of religion in Erik H. Eriksons theory of human development

Béatrix

Béatrix

Police field operations

Police field operations

Leasing

Leasing

Bad Beginning (Series of Unfortunate Events

Bad Beginning (Series of Unfortunate Events

The women of Brewster Place

The women of Brewster Place

Spiritual linkage with Russians

Spiritual linkage with Russians

Local Birds of North Central Texas

Local Birds of North Central Texas

Constitutional law

Constitutional law

The moon

The moon

Glycation hypothesis of atherosclerosis by Camilo A. L. S. Colaco Download PDF EPUB FB2

All of these findings are consistent with, though do not prove, the hypothesis that high glucose concentrations contribute directly to the acceleration of atherosclerosis in diabetes.

One mechanism by which hyperglycemia may cause complications is through increased glycation, the spontaneous, nonenzymatic reaction of glucose with by:   The Glycation Hypothesis of Atherosclerosis (Medical Intelligence Unit) [Camilo A.

Colaco] on *FREE* shipping on qualifying offers. Landes). Quadrant Healthcare, Cambridge, Glycation hypothesis of atherosclerosis book. Research for clinicians and investigators. 10 contributorsCited by:   The Glycation Hypothesis of Atherosclerosis (Medical Intelligence Unit) [Camilo A.L.S.

Colaco] on *FREE* shipping on qualifying offers. As cardiovascular disease is a major cause of death in the western world, it is essential that we understand the pathogenesis of atherosclerosis.

Although cholesterol has caught the public's attention. The glycation hypothesis of atherosclerosis. [Camilo A L S Colaco] Home. WorldCat Home About WorldCat Help. Search. Search for Library Items Search for Lists Search for Book: All Authors / Contributors: Camilo A L S Colaco.

Find more information about: ISBN: Glycation and Atherosclerosis. Glycation refers to the irreversible binding of glucose with proteins and lipids and is an important factor in the pathogenesis of atherosclerosis.

Understanding the process of glycation leads to greater insight into mechanistic link between glycation, CVD, and cognitive deficits. Advanced glycation end products (AGEs) are proteins or lipids that become glycated after exposure to sugars. These compounds are present in the diabetic vasculature in which they have a relevant role in atherosclerosis.

1 AGEs contribute to a variety of microvascular and macrovascular complications through the formation of cross-links between molecules in the basement membrane of.

INTRODUCTION. Advanced glycation end products (AGEs) are a heterogeneous group of bioactive molecules formed by the non-enzymatic glycation of proteins, lipids, and nucleic acids (1,2).AGEs have been implicated in the pathogenesis of diabetes (), atherosclerosis (1,3), and renal disease ().AGEs form covalent cross-links with proteins such as collagen (), enhance the synthesis of extracellular.

Elevated serum iron level is linked with an increased risk of diabetes and atherosclerosis. However, the pathological mechanism by which iron affects serum lipoprotein levels is unknown. To elucidate the mechanism, a high dose of ferrous ion was applied (final 60 µM, µM) to human serum lipoproteins, macrophages, and human dermal fibroblast (HDF) cells.

Iron-treated lipoproteins showed. Title: Advanced Glycation End Products (AGEs) and Diabetic Vascular Complications VOLUME: 1 ISSUE: 1 Author(s):Sho-ichi Yamagishi, Kazuo Nakamura and Tsutomu Imaizumi Affiliation:Department of Internal Medicine III, Kurume University School of Medicine, KurumeJapan.

Keywords:diabetic vascular complications, atherosclerosis, ages, oxidative stress, rage, renin. Shyam Seetharaman, in Molecular Basis of Nutrition and Aging, Glycation and Atherosclerosis.

Glycation refers to the irreversible binding of glucose with proteins and lipids and is an important factor in the pathogenesis of atherosclerosis.

Understanding the process of glycation leads to greater insight into mechanistic link between glycation, CVD, and cognitive deficits. Objective. Advanced glycation end-products are considered to be markers of oxidative stress and to be involved in the atherosclerotic process.

We investigated skin autofluorescence, which reflected advanced glycation end-product accumulation, in recently preeclamptic women and its relationship with intima-media thickness, which is a marker of atherosclerosis. Oxidative stress is a consequence of the use of oxygen in aerobic respiration by living organisms and is denoted as a persistent condition of an imbalance between the generation of reactive oxygen species (ROS) and the ability of the endogenous antioxidant system (AOS) to detoxify them.

The oxidative stress theory has been confirmed in many animal studies, which demonstrated that the. Age-dependent accumulation of advanced glycation endproducts is accelerated in combined hyperlipidemia and hyperglycemia, a process attenuated by L-arginine M.

E., and Thornaley, P.J.: Glycation and advanced glycation endproducts, in The glycation Hypothesis of Atherosclerosis, edited by Colaco, C., Landers Bioscience,pp.

57– 3. The role of advanced glycation end products (AGEs) in cardiovascular diseases is a matter of interest in the last years and the strong association between the action of AGEs on their receptor (RAGE) and atherosclerosis has attracted increased attention.

The aim of this chapter is to review the results of our laboratory and others on the molecular mechanisms triggered by AGEs in the. The hypothesis of oxidative modification in atherosclerosis, reviewed by Steinberg and others in several opportunities argues that the oxidation of low-density lipoprotein (LDL) is an early stage of the disease and that oxidized LDL (OxLDL) would contribute to atherogenesis [].

1 day ago  Advanced glycation end products (AGEs), which are the products of a non-enzymatic reaction between reducing sugars and other macromolecules, are critical in aging, as well as metabolic and degenerative diseases. To assess the involvement of AGEs in glaucoma, skin autofluorescence (sAF) level, which is a measurement of AGEs’ accumulation, was compared among Japanese.

Nicotine and methamphetamine are frequently abused in modern society, despite the increasing evidence of their addictive, neuropharmacological, and toxic effects.

Tobacco, the most widely abused substance, is the leading cause of preventable death in the United States, killing nearly half a million. Protection from diabetes-induced atherosclerosis and renal disease by D-carnosine-octylester: effects of early vs late inhibition of advanced glycation end-products in Apoe-null mice Diabetologia.

Apr;58(4) doi: /s Advanced glycation end product (AGE) formation may contribute to the progression of atherosclerosis, particularly in diabetes.

The present study explored atherosclerosis in streptozotocin-induced diabetic apolipoprotein E–deficient (apoE−/−) mice that were randomized (n = 20) to receive for 20 weeks no treatment, the AGE cross-link breaker ALT, or the inhibitor of AGE formation.

Our study aimed to identify the relationship between advanced glycation end products (AGEs), soluble receptor for advanced glycation end products (sRAGE), the AGEs/sRAGE, and uric acid (UA) levels in selected atherosclerosis diseases, i.e., abdominal aortic aneurysms (AAA), aortoiliac occlusive disease (AIOD), and chronic kidney disease (CKD.

fore tested the hypothesis that PIO could alleviate inflammation and atherosclerosis partly through inhibit-ing AGE-induced classical macrophage polarization in diabetic mice fed a high-fat diet.

Results PIO induces bone marrow-derived macrophages (BMDMs) into an anti-inflammatory status It is known that M1 macrophages predominantly.Glycation by glucose and glycation by MG in the presence of aminoguanidine produced LDL derivatives that were without similar effect.

Oxidized LDL was more susceptible to aggregation than MG min-LDL in this evaluation (Fig. 1D). Arginine-directed glycation by MG, however, is a novel nonoxidative modification that stimulates LDL aggregation.AGEs–RAGE Axis.

AGEs are heterogeneous group of irreversible adducts resulting from the nonenzymatic glycation and glycoxidation of proteins, nucleic acid, and lipids.

33 Glucose interacts with free amino group of lysine or arginine, producing Schiff bases, which are rapidly transformed into Amadori products. A series of complex reactions results in the formation of AGEs including Nέ.